Catheter Precision (VTAK) Long-Term Deferred Tax (2022 - 2023)
Catheter Precision's (VTAK) quarterly Long-Term Deferred Tax came in at $26.8 million in Q4 2023, up 207.88% year-on-year from $8.7 million in Q4 2022, and up 207.88% on a QoQ basis from $8.7 million in Q4 2022.
Catheter Precision (VTAK) Long-Term Deferred Tax (2022 - 2023) Analysis & Trends
Catheter Precision (VTAK) has 2 years of Long-Term Deferred Tax data on file, last reported at $26.8 million in Q4 2023.
- On a quarterly basis, Long-Term Deferred Tax rose 207.88% year-over-year to $26.8 million in Q4 2023; TTM through Dec 2023 was $26.8 million, a 207.88% increase from a year earlier, with the FY2023 full-year figure at $26.8 million, up 207.88% from the prior year.
- Long-Term Deferred Tax for Q4 2023 stood at $26.8 million, up from $8.7 million in the prior quarter.
- Over the last five years, Long-Term Deferred Tax for VTAK reached as high as $26.8 million in Q4 2023 and fell as low as $8.7 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Catheter Precision | 0.80 | -811,999.20 | 390,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 26.77 Mn |
| Dec 31, 2022 | 8.69 Mn |